MOTS-c 10mg
MOTS-c 10mg $269.00
Back to products
TB-500 (10mg)
TB-500 (10mg) $229.00
Reta + Cagri Blend (5mg + 5mg) - Image 1

Reta + Cagri Blend (5mg + 5mg)

$359.00

Retatrutide 5mg and Cagrilintide 5mg Blend.  Premium Grade >99% Purity. Please allow for 10 days shipping due to our Valentine’s Day sale.

Add to wishlist
SKU: TS-1256-1-3 Category:
Description

Potential Benefits of a Retatrutide + Cagrilintide Blend:

  1. Strong Synergistic Weight-Loss Support

Retatrutide (a triple GLP-1/GIP/Glucagon agonist) and Cagrilintide (an amylin analogue) act on multiple appetite and metabolic pathways, showing greater combined weight-loss effects than GLP-1 medications alone.

  1. Powerful Appetite Suppression

Both compounds reduce hunger through different mechanisms:

  • Retatrutide reduces appetite and slows gastric emptying
  • Cagrilintide enhances satiety and lowers cravings
    Together they may dramatically improve adherence to lower calorie intake.
  1. Reduced Food Cravings & Snacking

Cagrilintide’s amylin-based effect is particularly strong for reducing cravings, late-night eating, and emotional snacking.

  1. Enhanced Fat-Burning Pathways

Retatrutide’s glucagon receptor activity may help increase:

  • fat oxidation
  • energy expenditure
  • reduction in visceral fat

This makes the combination potentially effective for stubborn abdominal fat.

  1. Greater Fullness After Meals

Both compounds slow gastric emptying, helping users feel full quickly and stay full longer.

  1. Stabilized Blood Sugar Levels

Retatrutide’s GLP-1 and GIP activity can help support:

  • improved insulin sensitivity
  • reduced glucose spikes
  • steadier energy levels

This can reduce overeating caused by high/low blood sugar swings.

  1. Strong Anti-Overeating Signal (Amylin Pathway Activation)

Cagrilintide activates the amylin pathway, which is involved in:

  • meal size control
  • stopping eating sooner
  • reducing reward-based eating

This complements Retatrutide’s metabolic effects.

  1. Potentially Faster & More Significant Body-Weight Reduction

Early studies showed Retatrutide alone produced up to ~24% weight reduction.
Combining it with an amylin analogue may enhance this further due to dual appetite + metabolic targeting.

  1. Support for Cardiometabolic Health

Research suggests improvements in:

  • cholesterol levels
  • blood pressure
  • inflammation markers
  • liver fat
    These improvements are linked to weight loss and GLP-1/GIP/glucagon effects.
  1. Smaller, More Manageable Doses Needed

Because the blend is synergistic, users may require less frequent titration and experience stronger appetite regulation earlier.

Important Notes

    • Retatrutide and Cagrilintide are investigational compounds, not FDA/TGA-approved therapies.
    • Effects listed are based on early research, animal studies, mechanistic data, or clinical trials in progress.
    • This is not medical advice and is for informational purposes only.